BridgeBio Oncology Therapeutics Common Stock Net 1970-1969 | BBOT

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

BridgeBio Oncology Therapeutics common stock net from 1970 to 1969. Common stock net can be defined as the value of common equity ownership.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

BridgeBio Oncology Therapeutics common stock net from 1970 to 1969. Common stock net can be defined as the value of common equity ownership.

Related Stocks
Company Name	Market Cap
AstraZeneca (AZN)	$247.8B
Amgen (AMGN)	$154.9B
Gilead Sciences (GILD)	$140.2B
Vertex Pharmaceuticals (VRTX)	$100.3B
Bristol Myers Squibb (BMY)	$96B
GSK (GSK)	$80.8B
CSL (CSLLY)	$67.1B
Regeneron Pharmaceuticals (REGN)	$61.5B
Alnylam Pharmaceuticals (ALNY)	$58.5B
Argenex SE (ARGX)	$43.6B
Insmed (INSM)	$28.8B
BioNTech SE (BNTX)	$24B
Royalty Pharma (RPRX)	$21B
Biogen (BIIB)	$19.4B
Incyte (INCY)	$16.5B
Genmab (GNMSF)	$16.5B
Genmab (GMAB)	$16B
Illumina (ILMN)	$15.4B
Ascendis Pharma (ASND)	$11.9B
BioMarin Pharmaceutical (BMRN)	$11.2B
Swedish Orphan Biovitrum (BIOVF)	$10.9B
QIAGEN (QGEN)	$10.3B
Exelixis (EXEL)	$10.1B
Moderna (MRNA)	$9.4B
Verona Pharma American Depositary Share (VRNA)	$9.2B
Exact Sciences (EXAS)	$9B
Bio-Techne Corp (TECH)	$8.6B
Halozyme Therapeutics (HALO)	$8.6B
Guardant Health (GH)	$8.4B
Blueprint Medicines (BPMC)	$8.3B